Cleopatra Hospital Co (CAI:CLHO) 3-Year RORE % : 11.11% (As of Mar. 2026)


CAI:CLHO Cleopatra Hospital Co CAI:CLHO
89 GF Score
Price E£16.37
GF Value E£14.01
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Cleopatra Hospital Co 3-Year RORE %?

Cleopatra Hospital Co CAI:CLHO +0.43% 89 3-Year RORE % is 11.11 as of Mar. 2026. GuruFocus rates CAI:CLHO with a GF Score™ of 89/100 and a GF Value™ of E£14.01 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Cleopatra Hospital Co ranks better than 61.39% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Cleopatra Hospital Co's 3-Year RORE % for the quarter that ended in Mar. 2026 was 11.11%.

The industry rank for Cleopatra Hospital Co's 3-Year RORE % or its related term are showing as below:

CAI:CLHO's 3-Year RORE % is ranked better than
61.39% of 606 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs CAI:CLHO: 11.11

Cleopatra Hospital Co  (CAI:CLHO) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Cleopatra Hospital Co 3-Year RORE % Related Terms


Cleopatra Hospital Co 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Cleopatra Hospital Co's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleopatra Hospital Co 3-Year RORE % Chart

Cleopatra Hospital Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.13 3.29 3.41 28.70 22.43

Cleopatra Hospital Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.02 27.94 26.23 22.43 11.11

CAI:CLHO vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Cleopatra Hospital Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleopatra Hospital Co 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Cleopatra Hospital Co's 3-Year RORE % falls into.


CAI:CLHO
89GF Score
Cleopatra Hospital Co CAI:CLHO
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleopatra Hospital Co 3-Year RORE % Calculation

Cleopatra Hospital Co's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.4-0.28 )/( 1.08-0 )
=0.12/1.08
=11.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 11.11 mean?
Cleopatra Hospital Co (CAI:CLHO) has a 3-Year RORE % of 11.11 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Cleopatra Hospital Co and its competitors. According to the industry distribution chart, Cleopatra Hospital Co ranks #234 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 38.6%.
Is Cleopatra Hospital Co's 3-Year RORE % too high?
Cleopatra Hospital Co's current 3-Year RORE % is 11.11. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. Cleopatra Hospital Co's value of 11.11 is 5597.4% above this industry median. Based on the distribution chart, Cleopatra Hospital Co ranks #234 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cleopatra Hospital Co has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cleopatra Hospital Co ranks #234 out of 606 companies for 3-Year RORE %. This puts Cleopatra Hospital Co in the upper half of its industry. The industry median 3-Year RORE % is 0.20. Cleopatra Hospital Co's value of 11.11 is 5597.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current 3-Year RORE % of 11.11 is 5597.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Cleopatra Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current 3-Year RORE % is 11.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£14.01, compared to a current price of E£16.37 — trading 16.8% above its estimated fair value. The current 3-Year RORE % is 11.11 and 5597.4% above the Healthcare Providers & Services industry median of 0.20. Cleopatra Hospital Co's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current 3-Year RORE % is 11.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?

Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued. The current stock price of E£16.37 is trading 16.8% above its estimated GF Value™ of E£14.01. GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.

Key valuation signals for CAI:CLHO:

  • 3-Year RORE %: 11.11
  • GF Value™: E£14.01 vs. price of E£16.37 (16.8% above fair value)
  • GF Score™: 89/100 with 5 warning signs
  • Industry Position: 5597.4% above the Healthcare Providers & Services median (#234 of 606)

No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cleopatra Hospital Co Business Description

Address 39, 41 Cleopatra street, Heliopolis, Cairo, EGY
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
89GF Score

Get the complete analysis for CAI:CLHO

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£16.37
Price
E£14.01
GF Value